{"id":994,"date":"2021-03-26T12:41:44","date_gmt":"2021-03-26T09:41:44","guid":{"rendered":"https:\/\/www.chemi-pharm.com\/?p=994"},"modified":"2021-04-14T09:37:01","modified_gmt":"2021-04-14T06:37:01","slug":"ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast","status":"publish","type":"post","link":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/","title":{"rendered":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &#8220;HOMMIK ANUGA&#8221; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST"},"content":{"rendered":"\n<p>SARS-CoV-2 BioBlock&nbsp;ei ole ravim, vaid viirusvastane ennetava toimega preparaat, mis t\u00f6\u00f6tab ninaneelus limaskestade pinnal, kus see saab spetsiifiliselt inaktiveerida Covid-19 tekitajat SARS CoV-2 viirust. SARS-CoV-2 BioBlock nina- ja kurgusprei ei asenda ka vaktsineerimist, ega maski kandmist, vaid on lisameede viirusahelate katkestamisel. SARS-CoV-2 BioBlock nina- ja kurguspreist v\u00f5iks olla abi k\u00f5ikjal, kus sotsiaalne distantseerumine ja maski kandmine on keeruline: kodus, t\u00f6\u00f6kohal, restoranis, koolis, trennis, transpordivahendis ja teistes rahvarohketes kohtades. Toodet oleks soovitatav kasutada ka nakatunutel, et v\u00e4henda nende l\u00e4hikontaktsete nakatumise ohtu. Lisaks saab preparaadiga toetada vaktsineerituid ka uute, kergemini levivate Suurbritannia, L\u00f5una-Aafrika ja Brasiilia viirusvariantide puhul.<\/p>\n\n\n\n<p>Ternespiima looduslik roll imetajatel on pakkuda vasts\u00fcndinule esmane kaitsev immuunsus ema organismi poolt toodetud antikehade abil. Erinevalt inimesest ei ole lehma antikehad suutelised l\u00e4bima platsentat ning vasts\u00fcndinud vasikas omandab emalt antikehad ainult ternespiimaga. P\u00e4rast s\u00fcndi joodetakse farmides vasikale 24 tunni jooksul ternespiima, mille tulemusena omandab vasts\u00fcndinud j\u00e4rglane passiivse immuunsuse karjas levivate erinevate haigustekitajate (viiruste, bakterite ja allergeenide) suhtes. Samas poegimisj\u00e4rgselt tekkivast ternespiimast kasutatakse \u00e4ra vaid v\u00e4ikene osa (umbes 2 liitrit) vasikatele immuuns\u00fcsteemi rekonstrueerimiseks \u2013 \u00fclej\u00e4\u00e4nud osa on seni suuresti kasutamata ressurss. Esimesest ternespiimast tekkinud vadaku valkudest enam kui poole moodustavad k\u00f5rgel kontsentratsioonil antikehad, mida on v\u00f5imalik sealt saada kuni 500 grammi. Antikehade koostist ternespiimas on v\u00f5imalik muuta tiinete lehmade immuniseerimisega, kasutades selleks kommertsiaalseid vaktsiine v\u00f5i haigustekitajate antigeene, n\u00e4iteks viirusvalke, andes ternespiimale uusi, spetsiifilisi kaitsetoimeid. See unikaalne looduslik ise\u00e4rasus loob suured v\u00f5imalused vasts\u00fcndinud j\u00e4rglaste vastupanuv\u00f5ime parandamiseks karjas levivate nakkushaiguste suhtes, aga loob ka v\u00f5imalused inimestele kasulike preparaatide loomiseks ternespiimast, mida on v\u00f5imalik kasutada nakkuste v\u00f5i allergiate v\u00e4ltimiseks, parandades seel\u00e4bi oluliselt inimeste elukvaliteeti.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-1024x576.png\" alt=\"\" class=\"wp-image-995\" width=\"768\" height=\"432\" srcset=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-1024x576.png 1024w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-300x169.png 300w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-768x432.png 768w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-1536x864.png 1536w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-2048x1152.png 2048w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-1920x1080.png 1920w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-600x338.png 600w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Tootmisprotsessi_kirjeldus_sars_cov2_bioblock-200x113.png 200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/figure>\n\n\n\n<p>Meie konsortsium kasutas lehmade immuniseerimiseks tiinuse kolmandal trimestril mittenakkuslikku rekombinantset SARS-CoV-2 ogavalku, mille suhtes tekkisid teatud aja j\u00e4rel lehmade verre lisaks uued SARS CoV-2 vastased viirust neutraliseerivad antikehad. Immuniseerimiseks kasutatud koroonaviiruse ogavalk on sarnane sellele, mida kasutatakse inimestele m\u00f5eldud vaktsiinides. Ootusp\u00e4raselt liikusid vahetult enne poegimist enamus tekkinud antikehadest verest piiman\u00e4\u00e4rmetesse ja sealt ternespiima, mida kasutasime antikehade tootmise l\u00e4htematerjalina. Me t\u00f6\u00f6tasime v\u00e4lja tehnoloogia ternespiima antikehade puhastamiseks, mille k\u00e4igus eemaldasime laktoosi, valdava enamuse piimavalkudest ja steriliseerisime preparaadi v\u00f5imalike viiruste ja bakterite suhtes happet\u00f6\u00f6tluse, past\u00f6riseerimise ja membraanfiltreerimisega. Eelmisel n\u00e4dalal andis Icosagen konsortsiumi inventorite nimel sisse patenditaotluse USA patendiametile (nr. 63\/160833) SARS CoV-2 viirust neutraliseerivate antikehade preparaadi tehnilise protsessi kaitsmiseks. Tulevase patendi kommertsiaalsed \u00f5igused jaotatakse konsortsiumi partnerite vahel vastavalt intellektuaalomandi haldamise lepingule. Selles patenditaotluses kaitseme me intellektuaalomandit taoliselt loodud antikehade preparaadi kasutamiseks nina- ja kurguspreina, et hoida \u00e4ra nakatumist SARS CoV-2-sse v\u00f5i v\u00e4hendamaks nakatunute ninaneelus viiruse tiitrit.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"position: relative; width: 100%; height: 0; padding-bottom: 56.25%;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: none;\" src=\"\/\/services.err.ee\/media\/embed\/1224799\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"601\" src=\"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-1024x601.jpg\" alt=\"\" class=\"wp-image-1300\" srcset=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-1024x601.jpg 1024w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-300x176.jpg 300w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-768x451.jpg 768w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-600x352.jpg 600w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-200x117.jpg 200w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg 1091w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"SARS-CoV-2 BioBlock&nbsp;ei ole ravim, vaid viirusvastane ennetava toimega preparaat, mis t\u00f6\u00f6tab ninaneelus limaskestade pinnal, kus see saab spetsiifiliselt inaktiveerida Covid-19 tekitajat SARS CoV-2 viirust. SARS-CoV-2 BioBlock nina- ja kurgusprei ei asenda ka vaktsineerimist, ega maski kandmist, vaid on lisameede viirusahelate katkestamisel. SARS-CoV-2 BioBlock nina- ja kurguspreist v\u00f5iks olla abi k\u00f5ikjal, kus sotsiaalne distantseerumine ja maski [&hellip;]","protected":false},"author":1,"featured_media":1300,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-994","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-est"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &quot;HOMMIK ANUGA&quot; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &quot;HOMMIK ANUGA&quot; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm\" \/>\n<meta property=\"og:description\" content=\"SARS-CoV-2 BioBlock&nbsp;ei ole ravim, vaid viirusvastane ennetava toimega preparaat, mis t\u00f6\u00f6tab ninaneelus limaskestade pinnal, kus see saab spetsiifiliselt inaktiveerida Covid-19 tekitajat SARS CoV-2 viirust. SARS-CoV-2 BioBlock nina- ja kurgusprei ei asenda ka vaktsineerimist, ega maski kandmist, vaid on lisameede viirusahelate katkestamisel. SARS-CoV-2 BioBlock nina- ja kurguspreist v\u00f5iks olla abi k\u00f5ikjal, kus sotsiaalne distantseerumine ja maski [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemi-Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chemipharmeesti\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-26T09:41:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-14T06:37:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1091\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"reaktiiv-ch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/\"},\"author\":{\"name\":\"reaktiiv-ch\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/0b083f60748961b80b42beaf7f40832d\"},\"headline\":\"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &#8220;HOMMIK ANUGA&#8221; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST\",\"datePublished\":\"2021-03-26T09:41:44+00:00\",\"dateModified\":\"2021-04-14T06:37:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/\"},\"wordCount\":457,\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Untitled-1-copy.jpg\",\"articleSection\":[\"Uudised eestikeelsed\"],\"inLanguage\":\"et\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/\",\"name\":\"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID \\\"HOMMIK ANUGA\\\" SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Untitled-1-copy.jpg\",\"datePublished\":\"2021-03-26T09:41:44+00:00\",\"dateModified\":\"2021-04-14T06:37:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Untitled-1-copy.jpg\",\"contentUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Untitled-1-copy.jpg\",\"width\":1091,\"height\":640},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &#8220;HOMMIK ANUGA&#8221; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"name\":\"Chemi-Pharm\",\"description\":\"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt\",\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\",\"name\":\"Chemi-Pharm\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"width\":282,\"height\":27,\"caption\":\"Chemi-Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chemipharmeesti\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/0b083f60748961b80b42beaf7f40832d\",\"name\":\"reaktiiv-ch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g\",\"caption\":\"reaktiiv-ch\"},\"sameAs\":[\"http:\\\/\\\/reaktiiv.ee\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID \"HOMMIK ANUGA\" SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/","og_locale":"et_EE","og_type":"article","og_title":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID \"HOMMIK ANUGA\" SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm","og_description":"SARS-CoV-2 BioBlock&nbsp;ei ole ravim, vaid viirusvastane ennetava toimega preparaat, mis t\u00f6\u00f6tab ninaneelus limaskestade pinnal, kus see saab spetsiifiliselt inaktiveerida Covid-19 tekitajat SARS CoV-2 viirust. SARS-CoV-2 BioBlock nina- ja kurgusprei ei asenda ka vaktsineerimist, ega maski kandmist, vaid on lisameede viirusahelate katkestamisel. SARS-CoV-2 BioBlock nina- ja kurguspreist v\u00f5iks olla abi k\u00f5ikjal, kus sotsiaalne distantseerumine ja maski [&hellip;]","og_url":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/","og_site_name":"Chemi-Pharm","article_publisher":"https:\/\/www.facebook.com\/chemipharmeesti","article_published_time":"2021-03-26T09:41:44+00:00","article_modified_time":"2021-04-14T06:37:01+00:00","og_image":[{"width":1091,"height":640,"url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg","type":"image\/jpeg"}],"author":"reaktiiv-ch","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#article","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/"},"author":{"name":"reaktiiv-ch","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/0b083f60748961b80b42beaf7f40832d"},"headline":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &#8220;HOMMIK ANUGA&#8221; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST","datePublished":"2021-03-26T09:41:44+00:00","dateModified":"2021-04-14T06:37:01+00:00","mainEntityOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/"},"wordCount":457,"publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg","articleSection":["Uudised eestikeelsed"],"inLanguage":"et"},{"@type":"WebPage","@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/","url":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/","name":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID \"HOMMIK ANUGA\" SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST - Chemi-Pharm","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#primaryimage"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg","datePublished":"2021-03-26T09:41:44+00:00","dateModified":"2021-04-14T06:37:01+00:00","breadcrumb":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#primaryimage","url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg","contentUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg","width":1091,"height":640},{"@type":"BreadcrumbList","@id":"https:\/\/test2.chemi-pharm.com\/et\/ruth-oltjer-ja-mart-ustav-raakisid-hommik-anuga-saates-sars-cov-2-bioblock-tehnoloogiast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test2.chemi-pharm.com\/et\/"},{"@type":"ListItem","position":2,"name":"RUTH OLTJER JA MART USTAV R\u00c4\u00c4KISID &#8220;HOMMIK ANUGA&#8221; SAATES SARS-COV-2 BIOBLOCK TEHNOLOOGIAST"}]},{"@type":"WebSite","@id":"https:\/\/test2.chemi-pharm.com\/et\/#website","url":"https:\/\/test2.chemi-pharm.com\/et\/","name":"Chemi-Pharm","description":"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt","publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test2.chemi-pharm.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization","name":"Chemi-Pharm","url":"https:\/\/test2.chemi-pharm.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","contentUrl":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","width":282,"height":27,"caption":"Chemi-Pharm"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chemipharmeesti"]},{"@type":"Person","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/0b083f60748961b80b42beaf7f40832d","name":"reaktiiv-ch","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/secure.gravatar.com\/avatar\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6ddf314383c45ea4e87cd8349b2f988ac0fabf7aa4b9a15206d901827b077806?s=96&d=mm&r=g","caption":"reaktiiv-ch"},"sameAs":["http:\/\/reaktiiv.ee"]}]}},"author_meta":{"display_name":"reaktiiv-ch","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/reaktiiv-ch\/"},"featured_img":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-300x176.jpg","uagb_featured_image_src":{"full":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg",1091,640,false],"thumbnail":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-150x150.jpg",150,150,true],"medium":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-300x176.jpg",300,176,true],"medium_large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-768x451.jpg",768,451,true],"large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-1024x601.jpg",1024,601,true],"1536x1536":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg",1091,640,false],"2048x2048":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy.jpg",1091,640,false],"news_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-600x352.jpg",600,352,true],"custom_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Untitled-1-copy-200x117.jpg",200,117,true]},"uagb_author_info":{"display_name":"reaktiiv-ch","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/reaktiiv-ch\/"},"uagb_comment_info":0,"uagb_excerpt":"SARS-CoV-2 BioBlock&nbsp;ei ole ravim, vaid viirusvastane ennetava toimega preparaat, mis t\u00f6\u00f6tab ninaneelus limaskestade pinnal, kus see saab spetsiifiliselt inaktiveerida Covid-19 tekitajat SARS CoV-2 viirust. SARS-CoV-2 BioBlock nina- ja kurgusprei ei asenda ka vaktsineerimist, ega maski kandmist, vaid on lisameede viirusahelate katkestamisel. SARS-CoV-2 BioBlock nina- ja kurguspreist v\u00f5iks olla abi k\u00f5ikjal, kus sotsiaalne distantseerumine ja maski&hellip;","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/test2.chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 5 aastat ago","modified":"Updated 5 aastat ago"},"absolute_dates":{"created":"Posted on 26. m\u00e4rts 2021","modified":"Updated on 14. apr. 2021"},"absolute_dates_time":{"created":"Posted on 26. m\u00e4rts 2021 12:41","modified":"Updated on 14. apr. 2021 09:37"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/comments?post=994"}],"version-history":[{"count":14,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/994\/revisions"}],"predecessor-version":[{"id":1304,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/994\/revisions\/1304"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media\/1300"}],"wp:attachment":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media?parent=994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/categories?post=994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/tags?post=994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}